WHO WE ARE
Positron Corporation is a nuclear medicine healthcare company specializing in the field of cardiac Positron Emission Tomography (PET) imaging - the gold standard diagnostic test in nuclear cardiology. Positron operates in a variety of business segments in areas combining cardiac PET imaging technology, radiopharmaceuticals and radioisotopes.
Our products and services enable healthcare providers to more accurately diagnose cardiac disease and improve patient outcomes while practicing cost effective medicine. Positron has focused exclusively on supporting the cardiac PET field for more than 30 years and is now facilitating the stabilization, security and growth of the industry.
Founded in 1983, Positron has gained significant traction in the industry based on its imaging technology and strong commitment towards advancing cardiac care. Originally a research & development company, Positron has expanded from a medical imaging device manufacturer to a nuclear healthcare company integrating the key components of the cardiac PET supply chain to provide an end-to-end solution for the market.
To facilitate the stabilization, security and growth of the cardiac PET industry by offering cardiologists a vertically integrated supply chain solution that combines: imaging technology, clinical support, innovative financing, radiopharmaceuticals and radioisotopes. Positron is the leading company developing an end-to-end solution and their approach will facilitate the adoption of cardiac PET and the growth of nuclear cardiology industry.